Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model
Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model. // Acta Pharmaceutica Sinica B. – URL: https://www.sciencedirect.com/science/article/pii/S3050623926000489?dgcid=rss_sd_all
Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model. Acta Pharmaceutica Sinica B. https://www.sciencedirect.com/science/article/pii/S3050623926000489?dgcid=rss_sd_all
“Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model.” Acta Pharmaceutica Sinica B.
@article{article13624,
title = {Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model},
journal = {Acta Pharmaceutica Sinica B},
url = {https://www.sciencedirect.com/science/article/pii/S3050623926000489?dgcid=rss_sd_all}
}
Publication date: Available online 5 October 2026 Source: Brain Network Disorders Author(s): Juanita Ramírez Mancera, Alexandra Ramos-Márquez, David F. Estupiñán-Pepinosa, Liz González, Oscar F. Zorro-Guío, Diego F. Gómez-Amarillo, Juan...